LAUSR

Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment

Sign Up to like & get
recommendations!
1 Published in 2022 at "Pharmaceutics"

DOI: 10.3390/pharmaceutics14091956

Abstract: Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs), which are currently explored for treatment of pathogenic infections, including tuberculosis (TB). These cyclic hydrophobic peptides have a unique bacterial target to the conventional… read more here.

Keywords: generation antibiotics; tuberculosis; future generation; acyldepsipeptide analogues ... See more keywords